BD wins 510(k) for intestinal bacteria diagnostic

Becton Dickinson (NYSE:BDX) said today that it won 510(k) clearance from the FDA for its molecular test that detects harmful intestinal bacteria causing infectious diarrhea.

With the approval of its BD Max extended enteric bacteria panel, the company said the majority of pathogens causing acute gastroenteritis can be detected on its automated BD Max molecular platform.

Get the full story at our sister site, Drug Delivery Business News.

The post BD wins 510(k) for intestinal bacteria diagnostic appeared first on MassDevice.

from MassDevice http://ift.tt/2qUFS8P